View cart “Genove Fluidbase Rederm 10% AHA Lotion250ml” has been added to your cart.
Melaklyr Anti Melasma Cream 30gm
රු5,820.00
Buy this product to earn 5 JP Loyalty Points.
Description
Provides important protection against damage induced by UV radiation. It is a highly effective DE pigmenting agent. Vitamin C regenerates oxidized vitamin E, the combination is synergistic, particularly in UV protection.
Reversing the signs of Ageing. Topical application of 5% MAP cream was an effective and well-tolerated treatment. Melaklyr Rejuvenates skin. Helps diminish and soften wrinkles and prevents lines by helping stimulate cell regeneration and collagen production. Can help diminish age spots thus ameliorates skin aging. Melaklyr is a more potent anti melasma choice. Melaklyr repairs prevent and reduce UVA and UVB sun damage. Melaklyr provides protection against the free radicals. It can improve skin density, skin elasticity, tone and texture and improve the skin’s overall appearance.
Category: Skin Care
Description
Reviews (0)
Only logged in customers who have purchased this product may leave a review.
Related products
C-Glos vitamin C serum
Genove Fluidbase Max 30ml
Reduces depth of facial wrinkles caused by muscles repeated contraction, specially those around eyes and forehead, promoting youthful appearance. Fluidbase MAX contains a stabilized tripeptide within a hydrolyzed vegetable protein, which attenuates signs of sun damage and preserves DNA structure preventing premature signs of aging.
Genove Fluidbase Rederm Cream 30ml
CHARACTERISTICS OF FLUIDBASE® RETINOL + VIT. C
Retinol+Vit. C increases the skin's elasticity and the thickness of the epidermis, reducing the depth of fine lines and wrinkles. Its formula, with hyaluronic acid, gives it moisturising properties.INSTRUCTIONS OF FLUIDBASE® RETINOL + VIT. C
Fluidbase Retinol + Vitamin C should be applied to a clean face twice a day, massaging gently into affected areas to help the cream's absorption and the proper release of Vitamin A.
Reviews
There are no reviews yet.